Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy

By Sumida Y.   Nakamura K.   Kanayama K.   Akiho H.   Teshima T.   Takayanagi R.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 698-710

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Selection and expansion of T cell from untreated patients with CLL: source of cells for immune reconstitution?

By Husebekk A.   Fellows V.   Read E.   Williams J.   Petrus M.   Gress R.   Fowler D.  

Cytotherapy, Vol. 2, Iss. 3, 2000-03 ,pp. : 187-193

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive T-cell therapy for CMV

By Barrett John  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 1-1

Ashgate Publishing Ltd

Access to resources Recommend Favorite

GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia

By Turin I.   Pedrazzoli P.   Tullio C.   Montini E.   La Grotteria M Carmela   Schiavo R.   Perotti C.   Locatelli F.   Carretto E.   Maccario R.   Siena S.   Montagna D.  

Cytotherapy, Vol. 9, Iss. 5, 2007-01 ,pp. : 499-507

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cytopathological and Microbiological Profile of Tuberculous Lymphadenitis in HIV-Infected Patients with Special Emphasis on Its Corroboration with CD4+ T-Cell Counts

By  

Acta Cytologica, Vol. 59, Iss. 2, 2015-04 ,pp. : 156-162

Karger

Access to resources Recommend Favorite